Skip to Content

New Drug Approvals Archive - August 2010

August 2010

Taxotere (docetaxel)

New Dosage Form Approved: August 5, 2010

Suprep (sodium sulfate, potassium sulfate, magnesium sulfate) Oral Solution

Date of Approval: August 5, 2010
Company: Braintree Laboratories, Inc.
Treatment for: Bowel Preparation

Suprep (sodium sulfate, potassium sulfate, magnesium sulfate) is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults.

Read more: Suprep (sodium sulfate, potassium sulfate, magnesium sulfate) FDA Approval History

ella (ulipristal acetate)

Date of Approval: August 13, 2010
Company: HRA Pharma
Treatment for: Postcoital Contraception

ella is a progesterone agonist/antagonist emergency contraceptive indicated for prevention of pregnancy following unprotected intercourse or a known or suspected contraceptive failure.

Read more: ella (ulipristal acetate) FDA Approval History

Tekamlo (aliskiren and amlodipine) Tablets

Date of Approval: August 26, 2010
Company: Novartis Pharmaceuticals Corporation
Treatment for: Hypertension

Tekamlo (aliskiren and amlodipine) is a direct renin inhibitor and calcium channel blocker combination indicated for the treatment of high blood pressure.

Read more: Tekamlo (aliskiren and amlodipine) FDA Approval History

New Drug Approvals Archive